<SEC-DOCUMENT>0001104659-24-081960.txt : 20240913
<SEC-HEADER>0001104659-24-081960.hdr.sgml : 20240913
<ACCEPTANCE-DATETIME>20240723171629
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-24-081960
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240723

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SilverBox Corp IV
		CENTRAL INDEX KEY:			0002015947
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				862754279
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1250 S. CAPITAL OF TEXAS HIGHWAY
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
		BUSINESS PHONE:		512-575-3637

	MAIL ADDRESS:	
		STREET 1:		1250 S. CAPITAL OF TEXAS HIGHWAY
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="tm248249d5_correspimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">July&nbsp;23, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. Securities and Exchange Commission<BR>
Division of Corporation Finance<BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office of Real Estate&nbsp;&amp; Construction<BR>
100 F Street, N.E.<BR>
Washington, D.C. 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 9%"><FONT STYLE="font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 91%"><FONT STYLE="font-size: 10pt">Ruairi Regan</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Brigitte Lippmann</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Babette Cooper</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Isaac Esquivel</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt"><B>Re: </B></FONT></TD>
    <TD STYLE="width: 95%"><FONT STYLE="font-size: 10pt"><B>SilverBox Corp IV</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Registration Statement on Form S-1</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Filed June 18, 2024</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File No. 333-280315</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">On
behalf of our client, SilverBox Corp IV (the &ldquo;<U>Company</U>,&rdquo; &ldquo;<U>we</U>,&rdquo; &ldquo;<U>our</U>&rdquo; or &ldquo;<U>us</U>&rdquo;),
we are responding to the comments from the staff (the &ldquo;<U>Staff</U>&rdquo;) of the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
in your letter dated July&nbsp;15, 2024 (the &ldquo;<U>Comment Letter</U>&rdquo;), with respect to the above-captioned Registration Statement
on Form&nbsp;S-1 (the &ldquo;<U>Registration Statement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">For
your convenience, each of the Staff&rsquo;s comments contained in the Comment Letter is duplicated below in bold and is followed by the
Company&rsquo;s response.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">All
references in this letter to page&nbsp;numbers and captions (other than those in the Staff&rsquo;s comments) correspond to the page&nbsp;numbers
in Amendment No.&nbsp;1 to the Registration Statement (the &ldquo;<U>Amended Registration Statement</U>&rdquo;), unless otherwise noted.
Defined terms used but not otherwise defined herein have the meanings ascribed to such terms in the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Registration Statement
on Form&nbsp;S-1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Cover Page</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>Please state whether the redemptions will be subject to any limitations,
such as the $5,000,001 net tangible asset requirement and for shareholders holding more than 15% of the shares sold in the offering. See
Item 1602(a)(2)&nbsp;of Regulation S-K. Also disclose the &ldquo;certain conditions as further described herein&rdquo; relating to the
redemptions or provide a cross-reference to the detailed disclosure in the prospectus.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the cover page&nbsp;of the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>Please revise your disclosure throughout the filing to reflect
that your sponsor will purchase 400,000 rather than 4,000,000 units.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on the cover page&nbsp;and pages&nbsp;1, 4, 27 and 111.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>With respect to the 350,000 private placement units that the
sponsor non-managing members have expressed an interest to purchase, please clarify whether these units are part of or in addition to
the 400,000 private placement units to be purchased by your sponsor.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have clarified the disclosure in the Amended Registration Statement on the cover page&nbsp;and pages&nbsp;4, 5, 27, 74, 111, 112, 162,
165 and F-14.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><FONT><B>In the paragraph where you disclose the payment for office space,
please also disclose the amount of loan reimbursements. See Item 1602(a)(3)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the cover page&nbsp;of the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><FONT><B>In the paragraph where you disclose the dilution relating to
the founder shares, also disclose that the anti-dilution adjustment to the founder shares may result in material dilution of the public
shares. See Item 1602(a)(3)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the cover page&nbsp;of the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>In the paragraph where you disclose conflicts of interest, please
highlight the cross-reference. See Item 1602(a)(5)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the cover page&nbsp;of the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.</B></TD><TD STYLE="text-align: justify"><FONT><B>In the paragraph where you disclose the financial advisory services
provided by SilverBox Securities, please state there may be actual material conflicts of interest between SilverBox Securities and purchasers
in the offering and provide a highlighted cross-reference to the detailed disclosure in the prospectus. See Item 1602(a)(3)&nbsp;and Item
1602(a)(5)&nbsp;of Regulation S K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the cover page&nbsp;of the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.</B></TD><TD STYLE="text-align: justify"><FONT><B>Please provide a cross-reference to all the sections in the prospectus
for disclosures related to each of compensation, dilution, and material conflicts of interest, as required by Item&nbsp;1602(a)(3), (4),
and (5)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the cover page&nbsp;of the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Summary, page&nbsp;1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.</B></TD><TD STYLE="text-align: justify"><FONT><B>In your table on page&nbsp;4, please also disclose the amount
of loan reimbursements and the anti-dilution adjustment of the founder shares. Also, describe the extent to which this compensation and
securities issuance may result in a material dilution of the purchasers&rsquo; equity interests. See Item 1602(b)(6)&nbsp;of Regulation
S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on page&nbsp;5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.</B></TD><TD STYLE="text-align: justify"><FONT><B>Please disclose your plans if you do not consummate a de-SPAC
transaction within 24 months, including whether you expect to extend the time period and whether there are any limitations on the number
of extensions, including the number of times. Also disclose the consequences to the sponsor of not completing an extension of this time
period. See Item 1602(b)(4)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;13 and 121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.</B></TD><TD STYLE="text-align: justify"><FONT><B>We note your disclosure that you may need to obtain additional
financing either to complete an initial business combination or because you become obligated to redeem a significant number of your public
shares. Please describe how additional financings may impact unaffiliated security holders. See Item 1602(b)(5)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;6, 15 and 107.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.</B></TD><TD STYLE="text-align: justify"><FONT><B>Where you disclose conflicts of interest throughout the filing,
as applicable, please also disclose that the executive officers of SilverBox III and SilverBox IV are identical and that SilverBox III
has not yet identified a target for a business combination. Therefore, there appears to be a material conflict of interest in seeking
potential targets. Also disclose the actual conflict of interest that SilverBox Securities LLC has in acting as your independent financial
advisor in connection with the offering. See Item 1602(b)(7)&nbsp;and Item 1603(b)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;3, 12, 13, 43, 44, 75, 76, 110, 120 and
156.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.</B></TD><TD STYLE="text-align: justify"><FONT><B>Under Conflicts of Interest, please disclose the nominal price
paid for the founder shares and the conflict of interest in determining whether to pursue a business combination. Also disclose the conflicts
of interest relating to repayment of loans, reimbursements of expenses, and the payment to SilverBox Securities that will be paid upon
completion of a business combination and the potential fees to SilverBox Securities for financial advisory services. Finally, disclose
the potential conflicts of interest arising from the ability to pursue a business combination with a company that is affiliated with members
of your management team, Founder Group or Advisory Group. See Item 1602(b)(7)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;43 and 44.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Risk Factors, page&nbsp;49</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.</B></TD><TD STYLE="text-align: justify"><FONT><B>With a view toward disclosure, please tell us whether your sponsor
is, is controlled by,&nbsp;has any members who are, or has substantial ties with, a non-U.S. person. Also revise&nbsp;your filing to include
risk factor disclosure that addresses how this fact could impact your&nbsp;ability to complete your initial business combination. For
instance, discuss the risk to&nbsp;investors that you may not be able to complete an initial business combination with a&nbsp;target company
should the transaction be subject to review by a U.S. government entity,&nbsp;such as the Committee on Foreign Investment in the United
States (CFIUS), or ultimately&nbsp;prohibited. Disclose that as a result, the pool of potential targets with which you could&nbsp;complete
an initial business combination may be limited. Further, disclose that the time&nbsp;necessary for government review of the transaction
or a decision to prohibit the&nbsp;transaction could prevent you from completing an initial business combination and&nbsp;require you
to liquidate. Disclose the consequences of liquidation to investors, such as the&nbsp;losses of the investment opportunity in a target
company, any price appreciation in the&nbsp;combined company, and the warrants, which would expire worthless.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We supplementally advise the Staff that our sponsor is a Delaware limited liability company, is controlled by our Chief Executive Officer
and Chairman, Stephen Kadenacy, and our Founding Partner, Joseph Reece, each of whom is a U.S. citizen. Further, the sponsor does not
have any substantial ties to a non-U.S. person, and, other than our Chief Investment Officer, Duncan Murdoch, no other member of the sponsor
is a non-U.S. person. Mr.&nbsp;Murdoch is an Australian citizen. Further, Mr.&nbsp;Murdoch does not control the sponsor and holds an immaterial
interest in the sponsor. Accordingly, we advise the Staff that the Registration Statement need not be revised to include the additional
risk factor disclosure as it is not a material risk to our ability to consummate an initial business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>If we are deemed to be
an investment company under the Investment Company Act, page&nbsp;75</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>15.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>Please revise your disclosure in this section to state clearly
that&nbsp;if you are found to&nbsp;be operating as an unregistered investment company, you may be required to change your&nbsp;operations
or&nbsp;wind down your operations. Also include disclosure with respect to the consequences to&nbsp;investors if you are required to wind
down your operations as a result of this status, such&nbsp;as the losses of the investment opportunity in a target company, any price
appreciation in&nbsp;the combined company, and any warrants, which would expire worthless. Please confirm that if your facts and circumstances&nbsp;change
over time, you will update your disclosure to reflect how those changes impact&nbsp;the risk that you may be considered to be operating
as an unregistered investment&nbsp;company.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;79 and 80.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Proposed Business, page&nbsp;107</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>16.</B></TD><TD STYLE="text-align: justify"><FONT><B>Under Overview, please also describe the experience of the sponsor
in organizing Boxwood Merger Corp. and the business combination with Atlas Technical Consultants,&nbsp;Inc. Also disclose that SilverBox
III has not yet identified a target for a business combination. See Item 1603(a)(3)&nbsp;of Regulation S-K.&nbsp; Please clarify how opportunities
to acquire&nbsp;targets are allocated among SPACs.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;110, 111 and 156.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>17.</B></TD><TD STYLE="text-align: justify"><FONT><B>Under Our Sponsor, based on the indications of interest by the
sponsor non-managing members and the intentions of each Advisory Group member to invest in the sponsor, please disclose the persons who
may have direct and indirect material interests in the sponsor, as well as the nature and amount of their interests. See Item 1603(a)(7)&nbsp;of
Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We respectfully advise the Staff that none of the sponsor non-managing members has a material interest in our sponsor; accordingly, no
additional disclosure is required pursuant to Item 1603(a)(7)&nbsp;of Regulation S-K. As disclosed in the Registration Statement, none
of the sponsor non-managing members will hold voting interests in our sponsor nor have any rights to control our sponsor or to vote or
dispose of any securities held by our sponsor. We note that the sponsor non-managing members are large institutional investors and the
proposed investment by such institutional investors in our sponsor represents one of many similar investments in other sponsors of special
purpose acquisition companies, where the complete loss of any such investments, including the proposed investment in our sponsor, would
not have an adverse effect on any such institutional investors. We have also eliminated all references to the Advisory Group in the Amended
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>18.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>In the table on page&nbsp;108, please also describe the amount
of loan reimbursements, the anti-dilution adjustment of the founder shares, and repayment of out-of-pocket expenses. Also disclose that
in addition to the services agreement with SilverBox Securities in connection with this offering, you may pay SilverBox Securities fees
for services provided after the offering. Finally, disclose the circumstances under which the sponsor, directly or indirectly, has transferred
or could transfer ownership of your securities to the sponsor non-managing members and the Advisory Group members. See Item 1603(a)(6)&nbsp;of
Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on page&nbsp;112.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>19.</B></TD><TD STYLE="text-align: justify"><FONT><B>In the table on page&nbsp;109, please also describe the lock
up agreement with the underwriter referred to on page&nbsp;197 and the transfers permitted by virtue of the sponsor&rsquo;s LLC agreement
referenced in romanette (iv). See Item 1603(a)(9)&nbsp;of Regulation S-K. Also explain how these restrictions relate to your agreements
with the sponsor non-managing members, the Advisory Group members, and any other potential sponsors. Also disclose any circumstances under
which the sponsor could forfeit securities, such as in connection with a de-SPAC. See Item 1603(a)(6)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;114, 130, 134, 159 and 163. As regards the transfer
restrictions and how they relate to the sponsor non-managing members, we advise the Staff that the sponsor non-managing members will only
hold Company securities indirectly through non-controlling and non-voting membership interests in our sponsor. Our sponsor cannot transfer
any Company securities directly to the sponsor non-managing members until the lock-up periods specified in the Registration Statement
expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Management, page&nbsp;145</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>20.</B></TD><TD STYLE="text-align: justify"><FONT><B>Under Conflicts of Interest and throughout the filing you refer
to your Advisory Group without identifying the individual members or describing any actual or potential material conflicts of interest
related to these members. Please identify the members in your Advisory Group and describe the specific material conflicts of interests.
File any agreements with any members of your Advisory Group as exhibits.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have eliminated all references to the Advisory Group in the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>21.</B></TD><TD STYLE="text-align: justify"><FONT><B>Please state the basis for your statement that you do not believe
that the fiduciary, contractual or other obligations or duties of your officers or directors will materially affect your ability to complete
a business combination.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;13, 43, 120 and 156.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>22.</B></TD><TD STYLE="text-align: justify"><FONT><B>Under Conflicts of Interest, please disclose the nominal price
paid for the founder shares and the conflict of interest in determining whether to pursue a business combination. Also disclose the conflicts
of interest relating to repayment of loans, reimbursements of expenses, and the payment to SilverBox Securities that will be paid upon
completion of a business combination and the potential fees to SilverBox Securities for financial advisory services. Finally, disclose
the potential conflicts of interest arising from the ability to pursue a business combination with a company that is affiliated with members
of your management team, Founder Group or Advisory Group. See Item 1603(b)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;156, 157 and 158.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>23.</B></TD><TD STYLE="text-align: justify"><FONT><B>Please disclose any circumstances under which the sponsor may
forfeit shares in connection with a de-SPAC transaction, such as in connection with a PIPE financing or earnout&nbsp;provision.&nbsp;See
Item 1603(a)(6)&nbsp;of Regulation S-K.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;6 and 159.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Exhibits</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>24.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>Please file the services agreement with SilverBox Securities
as an exhibit.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have filed the agreement with SilverBox Securities LLC as Exhibit&nbsp;10.9 to the Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>General</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>25.</B></TD><TD STYLE="text-align: justify"><B>We note your disclosure that the sponsor non-managing members have indicated an interest to purchase
17,060,000 units in this offering at the offering price. We also note that the sponsor non-managing members may purchase a different amount
for which they indicated an interest in buying. So that investors will be able to understand the minimum amount of your securities that
will enter the public market through sales to the public, as opposed to the sponsor non-managing members, please disclose whether there
is a ceiling on the amount that may be purchased by the sponsor non-managing members and quantify any ceiling. If there is no ceiling,
disclose the potential material impact on the public investors.&nbsp; Additionally, please tell us whether the limited number of public
investors would impact the company&rsquo;s eligibility to list its securities on the NYSE. Please provide appropriate risk factor disclosure,
including the potential conflicts of interest with the sponsor non-managing members in approving your business combination and otherwise
exercising their rights as public shareholders because of their indirect ownership of founder shares and private placement units, and
the ability to pursue a business combination with a company that is affiliated with the sponsor non-managing members, as noted on page&nbsp;11.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on the cover page&nbsp;and pages&nbsp;29 and 162. Assuming the institutional
investors acquire 17,060,000 units in the offering, we advise the Staff that we do not expect there to be any adverse impact on our ability
to list our securities on NYSE. Additionally, we respectfully advise the Staff that the Amended Registration Statement contains risk factor
disclosure on pages&nbsp;72 and 74, regarding potential conflicts of interest for the sponsor non-managing members, specifically the following
risk factors: &ldquo;<I>The nominal purchase price paid by our sponsor for the founder shares may significantly dilute the implied value
of your public shares in the event we consummate an initial business combination, and our sponsor is likely to make a substantial profit
on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading
price of our ordinary shares to decline materially</I>,&rdquo; &ldquo;<I>The value of the founder shares following completion of our initial
business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our ordinary
shares at such time is substantially less than $10.00 per public share</I>&rdquo; and &ldquo;<I>Since our sponsor, officers and directors,
and any other holders of our founder shares, including any sponsor non-managing members, will lose their entire investment in us if our
initial business combination is not completed, a conflict of interest may arise in determining whether a particular business combination
target is appropriate for our initial business combination.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>26.</B></TD><TD STYLE="text-align: justify"><B>We note that the sponsor non-managing members have indicated an interest to purchase approximately
74% of the units in the public offering. Please identify the twelve institutional investors, the number of units that each of these investors
have indicated an interest in purchasing in the offering, and file any agreements with such investors as exhibits.&nbsp; Also, disclose
the maximum percentage of the offering that could be purchased by these investors.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We respectfully advise the Staff that we do not believe it is appropriate to disclose the identities of the institutional investors that
have expressed interest in purchasing units in the offering. As disclosed in the Registration Statement, none of the institutional investors
are affiliated with each other or with any members of the Company&rsquo;s management, our sponsor or any of its affiliates. We have not
entered into any written or oral agreements with any of the institutional investors regarding their expressions of interest. Accordingly,
there are no agreements between any of the institutional investors and us that could be filed with the Amended Registration Statement.
Further, the disclosure of the identities and indications of interest of the institutional investors creates a misleading impression to
public investors as we have no assurances that any of the institutional investors will acquire any units in the offering. Such disclosure
could be construed by other potential investors as a tacit endorsement of the offering by such institutional investors and could have
the unintended consequence of attracting such other potential investors to the offering based solely on the information that a particular
institutional investor has expressed interest in acquiring units in the offering as well as such institutional investor&rsquo;s level
of interest. Moreover, even if any of the institutional investors acquire units in the offering, none of the institutional investors will
be required to (i)&nbsp;hold or otherwise be prohibited from disposing of any such units; (ii)&nbsp;vote in favor our initial business
combination; or (iii)&nbsp;refrain from redeeming its shares in connection with our initial business combination. If, in fact, any of
the institutional investors acquire units in the offering, that results in such institutional investor beneficially owning more than 5%
of our outstanding Class&nbsp;A ordinary shares and/or public warrants, such institutional investor will have an obligation to file a
Schedule 13D or 13G to report its beneficial ownership, at which time the identity of such institutional investor as well as the amount
of securities actually acquired by such institutional investor will be publicly disclosed in the appropriate manner. We believe the Registration
Statement provides the appropriate level of disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>27.</B></TD><TD STYLE="text-align: justify"><B>Please disclose whether the sponsor non-managing members&rsquo; units would be subject to a lock up
agreement, including a lock up agreement with the underwriters.&nbsp;Also, please clarify whether the&nbsp;institutional investors would
be subject to any limitations on voting or disposition or otherwise with regard to the securities they may acquire in this offering.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on the cover page and on pages 2, 24, 29, 30, 40, 73, 75, 130,
134, 159, 162 and 163. We note that the Registration Statement included disclosure under the section &ldquo;Summary &ndash; The
Offering &ndash; Expressions of interest&rdquo; that the sponsor non-managing members will not be required to hold or otherwise be
prohibited from disposing of any securities acquired in the offering, or to vote any public shares in favor of our initial business
combination. We have added such disclosure elsewhere in the Amended Registration Statement on page&nbsp;75.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>28.</B></TD><TD STYLE="text-align: justify"><B>Please describe in greater detail the nature of the discussions or communications that SBXC officers
have had with business combination partners considered by SBXC in relation to a potential business combination outside of SBXC.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We have revised the disclosure in the Amended Registration Statement on pages&nbsp;3, 12, 110 and 119.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>29.</B></TD><TD STYLE="text-align: justify"><B>Please tell us whether SilverBox Securities LLC plans to make a market in the securities. If so, amend
the registration statement to register the market-making activities.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Response</U></FONT><FONT STYLE="background-color: white">:
We supplementally advise the Staff that Silverbox Securities LLC does not plan to make a market in the securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font-size: 10pt; margin: 0pt">July 23, 2024</P><P STYLE="margin: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Thank you for your attention to this response. If you have any questions
related to this letter, please contact the undersigned at (213) 683-6188.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jonathan Ko</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Jonathan Ko</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Paul Hastings LLP</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Stephen
Kadenacy, SilverBox Corp IV</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Joseph Reece, SilverBox Corp IV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dan Esters, SilverBox Corp IV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Ilir Mujalovic, Allen Overy Shearman Sterling US LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">William B. Nelson, Allen Overy Shearman Sterling US LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm248249d5_correspimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm248249d5_correspimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !* -X# 2(  A$! Q$!_\0
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M+Y7#>:6;&S&,=Q[T -_X1_6_^ARU/_P&M?\ XU1_PC^M_P#0Y:G_ . UK_\
M&JYB^\=>*M-N+:"\T&WAENFV0J6)WG(&!AO<?G6E!K_C9[F))O#,21%P'?S!
MD+GD_>H U?\ A'];_P"ARU/_ ,!;7_XU1_PC^M_]#EJ?_@-:_P#QJND-<IX0
M\47/B.YU2*XMXHA:2*BF,GYLEASG_=H G_X1_6_^ARU/_P !K7_XU1_PC^M_
M]#EJ?_@-:_\ QJMG4KE[+3+NZ10S0PO(%;H2H)_I7)>#O'Z:_>2V-]%#:W(
M:$(QQ*.X&>XQ^7T- &I_PC^M_P#0Y:G_ . UK_\ &J/^$?UO_H<M3_\  :U_
M^-5T6<_2N6\&^*+GQ))J*SV\,7V24(#&3\P.[KGZ4 3_ /"/ZW_T.6I_^ MK
M_P#&J/\ A'];_P"ARU/_ ,!K7_XU71.RHA9B H&23V%<'<^.M2U+49;3PMI0
MODBX:YDR$S[=,?B: -K_ (1_6_\ H<M3_P# :U_^-4?\(_K?_0Y:G_X#6O\
M\:K"N?$GCC2H6N;_ ,/VLEN@RWDL<@?4,W\JZW0-;M?$&EQW]J3M;Y71NJ-W
M!_/\L4 9_P#PCVM_]#EJ?_@+:_\ QJC_ (1_6_\ H<M3_P# :U_^-5LZCJ-M
MI6GS7UV^R"%=S-C/Y?RKA[7Q7XPUI/M.E:#;+9MG8]PY^8>Q+#_(H W_ /A'
M];_Z'+4__ :U_P#C5;=A;SVME'#<WDMY,N=T\JJK/DD\A !P..!VKB[+QOJM
MGK-MIOB72DLC<G;',C?+GIZD8SCD'O7>*<J#C% ',?$3_D1-2_[9?^C4KD_#
M'B7Q%8>';2VL?#,EY;H&V3AR ^6)]*ZSXB?\B)J7_;+_ -&I3OA_C_A"--_W
M7_\ 0VH R/\ A,/%O_0FS?\ ?QO_ (FJ?PJ=WN=>>1-CM,A9#_"<N<5Z3@>E
M>=?#'_D(>(_^OE?_ $)Z /1"<<UYK!>0>)OB6UW)+&=-TI,0L[@*TGJ,^^3G
M_9%=;XPUJ/0?#ES=,?WK@Q0J#@EV&!^77\*X/0?A?%J6B6MY?7=Q;S3+N\I5
M!VJ>G7OC^= %NUGMO"?Q+>*"9$TO4D!P&!1&.<=/]K(^C5Z<#D5Y%XF^&T6B
MZ'/J%G>3S/"0S*R@?*3@GCTZUZ/X8U9-;\.V=\N=SH%D!/(<<-^HH YCQ7HV
MLV_BBV\2Z)"MU-&GER0,,X&",XR,\'ZU"?B)J=C_ ,ACPO=VZ?WU+ ?JH_G5
MG5O%5QH/CQ;;4?DTB:,>7)AN"1U/.."#GCO74'7=':#>=4LO+(ZF=<?SH R?
M"EYX:U&2ZO-$B2*XE(:Y3:5;)).2.AYSR*ZC'%>7^"XX[OXA:OJ&F*5TQ58
M@85B2,  <=02/:O4>U 'G?Q#_P"1D\*\G_CY//\ P..O0P*\\^(?_(R^%/\
MKY/_ *''7H8Z4 +7G'PN_P"0AXB_Z[I_Z$]>CUYO\+O^0AXB_P"NZ?\ H3T
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'6U110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
